Tavneos Capsule
Product Images NDC 73556-168

4 FDA label images from Chemocentryx, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tavneos (NDC 73556-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chemocentryx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tavneos 01)

Chemical Structure (Tavneos 01)
Chemical structure diagram of avacopan, the active ingredient in TAVNEOS 10 mg capsules. The diagram displays the molecular arrangement, including rings and functional groups, clearly illustrating the compound's chemical bonds and atomic connections.*
FDA Label Image

Figure 1 (Tavneos 02)

Figure 1 (Tavneos 02)
A forest plot chart depicting sustained remission rates at Week 52 comparing TAVNEOS (avacopan) and Prednisone across various patient subgroups including background therapy, ANCA positivity, AAV status, and AAV type. The chart shows response differences with confidence intervals indicating whether TAVNEOS or Prednisone performed better in each subgroup.*
FDA Label Image

Principal Display Panel (180 Capsule Bottle Carton)

Principal Display Panel (180 Capsule Bottle Carton)
TAVNEOS 10 mg capsules label, containing avacopan. The label indicates 180 capsules per container, manufactured for ChemoCentryx, Inc. with Amgen branding. It includes dispensing instructions for pharmacists, storage conditions, and a warning to keep out of reach of children.*
FDA Label Image

Principal Display Panel (30 Capsule Bottle Carton)

Principal Display Panel (30 Capsule Bottle Carton)
TAVNEOS 10 mg capsules packaging label, containing avacopan as the active ingredient. The label states it is manufactured by ChemoCentryx, Inc., with a package size of 30 capsules. It includes storage instructions and pharmacist dispensing guidance to provide the medication guide to patients. The product is for oral use and labeled with NDC 73556-168-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.